Think you know the markets? See if you can guess this stock based on the clues and chart below. Answer is at the bottom.
- This company conceivably got good news for one of their main products on Tuesday night.
- The stock currently has Buy ratings at Needham, Wedbush, and Oppenheimer, and Sell ratings at SunTrust Robinson, Jefferies, and JMP Securities
- Sympathy plays include Gilead Sciences, Inc. GILD, PTCT Therapeutics, Inc. PTCT and Vertex Pharmaceuticals Incorporated VRTX.
Sarepta Therapeutics Inc SRPT
Loading...
Loading...
GILDGilead Sciences Inc
$96.86-1.32%
Edge Rankings
Momentum
89.57
Growth
39.14
Quality
55.36
Value
23.55
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in